0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Orthobiologics Market Research Report 2023
Published Date: March 2023
|
Report Code: QYRE-Auto-0C8950
Home | Market Reports | Health| Pharmacy
Global Orthobiologics Market Insights and Forecast to 2028
BUY CHAPTERS

Global Orthobiologics Market Research Report 2023

Code: QYRE-Auto-0C8950
Report
March 2023
Pages:117
QYResearch
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Global Orthobiologics Market

The global Orthobiologics market was valued at US$ 5289.6 million in 2022 and is anticipated to reach US$ 7262.8 million by 2029, witnessing a CAGR of 4.6% during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Orthobiologics is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Orthobiologics is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Orthobiologics include Medtronic, NuVasive, Inc., Stryker Corporation, Zimmer Biomet Holdings, Orthofix International N.V., Anika Therapeutics, Inc., DePuy Synthes (Johnson & Johnson), Bioventus and Arthrex, Inc., etc. in 2022, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Orthobiologics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Orthobiologics.
The Orthobiologics market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Orthobiologics market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Orthobiologics manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.

Key Segmentations

By Company

  • Medtronic
  • NuVasive, Inc.
  • Stryker Corporation
  • Zimmer Biomet Holdings
  • Orthofix International N.V.
  • Anika Therapeutics, Inc.
  • DePuy Synthes (Johnson & Johnson)
  • Bioventus
  • Arthrex, Inc.
  • SeaSpine Holdings Corporation
  • Sanofi-Aventis (Sanofi SA)
  • Djo Global, Inc.
  • Seikagaku Corporation
  • RTI Surgical, Inc.
  • Heraeus Holding GmbH
  • Fidia Pharma USA Inc.
  • TRB Chemedica International SA
  • Allosource
  • Musculoskeletal Transplant Foundation, Inc.
  • Ito

Segment by Type

  • Bone Growth Stimulators (BGS)
  • Viscosupplements
  • Bone Graft Substitute

Segment by Application

  • Hospitals
  • Ambulatory Surgical Centres
  • Orthopaedics Clinics

Consumption by Region

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Russia
  • Asia-Pacific
  • China
  • Japan
  • South Korea
  • India
  • Australia
  • Taiwan
  • Indonesia
  • Thailand
  • Malaysia
  • Latin America
  • Mexico
  • Brazil
  • Argentina
  • Middle East & Africa
  • Turkey
  • Saudi Arabia
  • UAE

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Orthobiologics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Orthobiologics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report.

Scope of Global Orthobiologics Market Report

Report MetricDetails
Report NameGlobal Orthobiologics Market
Base Year2022
Forecasted years2023-2029
Forecast unitsUSD
Report coverageRevenue and volume forecast, company share, competitive landscape, growth factors and trends
Geographic regions coveredNorth America, Europe, Asia Pacific, Latin America, Middle East & Africa
1 Orthobiologics Market Overview
1.1 Product Overview and Scope of Orthobiologics
1.2 Orthobiologics Segment by Type
1.2.1 Global Orthobiologics Market Value Comparison by Type (2023-2029)
1.2.2 Bone Growth Stimulators (BGS)
1.2.3 Viscosupplements
1.2.4 Bone Graft Substitute
1.3 Orthobiologics Segment by Application
1.3.1 Global Orthobiologics Market Value by Application: (2023-2029)
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centres
1.3.4 Orthopaedics Clinics
1.4 Global Orthobiologics Market Size Estimates and Forecasts
1.4.1 Global Orthobiologics Revenue 2018-2029
1.4.2 Global Orthobiologics Sales 2018-2029
1.4.3 Global Orthobiologics Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Orthobiologics Market Competition by Manufacturers
2.1 Global Orthobiologics Sales Market Share by Manufacturers (2018-2023)
2.2 Global Orthobiologics Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Orthobiologics Average Price by Manufacturers (2018-2023)
2.4 Global Orthobiologics Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Orthobiologics, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Orthobiologics, Product Type & Application
2.7 Orthobiologics Market Competitive Situation and Trends
2.7.1 Orthobiologics Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Orthobiologics Players Market Share by Revenue
2.7.3 Global Orthobiologics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Orthobiologics Retrospective Market Scenario by Region
3.1 Global Orthobiologics Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Orthobiologics Global Orthobiologics Sales by Region: 2018-2029
3.2.1 Global Orthobiologics Sales by Region: 2018-2023
3.2.2 Global Orthobiologics Sales by Region: 2024-2029
3.3 Global Orthobiologics Global Orthobiologics Revenue by Region: 2018-2029
3.3.1 Global Orthobiologics Revenue by Region: 2018-2023
3.3.2 Global Orthobiologics Revenue by Region: 2024-2029
3.4 North America Orthobiologics Market Facts & Figures by Country
3.4.1 North America Orthobiologics Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Orthobiologics Sales by Country (2018-2029)
3.4.3 North America Orthobiologics Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Orthobiologics Market Facts & Figures by Country
3.5.1 Europe Orthobiologics Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Orthobiologics Sales by Country (2018-2029)
3.5.3 Europe Orthobiologics Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Orthobiologics Market Facts & Figures by Country
3.6.1 Asia Pacific Orthobiologics Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Orthobiologics Sales by Country (2018-2029)
3.6.3 Asia Pacific Orthobiologics Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Orthobiologics Market Facts & Figures by Country
3.7.1 Latin America Orthobiologics Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Orthobiologics Sales by Country (2018-2029)
3.7.3 Latin America Orthobiologics Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Orthobiologics Market Facts & Figures by Country
3.8.1 Middle East and Africa Orthobiologics Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Orthobiologics Sales by Country (2018-2029)
3.8.3 Middle East and Africa Orthobiologics Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Orthobiologics Sales by Type (2018-2029)
4.1.1 Global Orthobiologics Sales by Type (2018-2023)
4.1.2 Global Orthobiologics Sales by Type (2024-2029)
4.1.3 Global Orthobiologics Sales Market Share by Type (2018-2029)
4.2 Global Orthobiologics Revenue by Type (2018-2029)
4.2.1 Global Orthobiologics Revenue by Type (2018-2023)
4.2.2 Global Orthobiologics Revenue by Type (2024-2029)
4.2.3 Global Orthobiologics Revenue Market Share by Type (2018-2029)
4.3 Global Orthobiologics Price by Type (2018-2029)
5 Segment by Application
5.1 Global Orthobiologics Sales by Application (2018-2029)
5.1.1 Global Orthobiologics Sales by Application (2018-2023)
5.1.2 Global Orthobiologics Sales by Application (2024-2029)
5.1.3 Global Orthobiologics Sales Market Share by Application (2018-2029)
5.2 Global Orthobiologics Revenue by Application (2018-2029)
5.2.1 Global Orthobiologics Revenue by Application (2018-2023)
5.2.2 Global Orthobiologics Revenue by Application (2024-2029)
5.2.3 Global Orthobiologics Revenue Market Share by Application (2018-2029)
5.3 Global Orthobiologics Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Medtronic
6.1.1 Medtronic Corporation Information
6.1.2 Medtronic Description and Business Overview
6.1.3 Medtronic Orthobiologics Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Medtronic Orthobiologics Product Portfolio
6.1.5 Medtronic Recent Developments/Updates
6.2 NuVasive, Inc.
6.2.1 NuVasive, Inc. Corporation Information
6.2.2 NuVasive, Inc. Description and Business Overview
6.2.3 NuVasive, Inc. Orthobiologics Sales, Revenue and Gross Margin (2018-2023)
6.2.4 NuVasive, Inc. Orthobiologics Product Portfolio
6.2.5 NuVasive, Inc. Recent Developments/Updates
6.3 Stryker Corporation
6.3.1 Stryker Corporation Corporation Information
6.3.2 Stryker Corporation Description and Business Overview
6.3.3 Stryker Corporation Orthobiologics Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Stryker Corporation Orthobiologics Product Portfolio
6.3.5 Stryker Corporation Recent Developments/Updates
6.4 Zimmer Biomet Holdings
6.4.1 Zimmer Biomet Holdings Corporation Information
6.4.2 Zimmer Biomet Holdings Description and Business Overview
6.4.3 Zimmer Biomet Holdings Orthobiologics Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Zimmer Biomet Holdings Orthobiologics Product Portfolio
6.4.5 Zimmer Biomet Holdings Recent Developments/Updates
6.5 Orthofix International N.V.
6.5.1 Orthofix International N.V. Corporation Information
6.5.2 Orthofix International N.V. Description and Business Overview
6.5.3 Orthofix International N.V. Orthobiologics Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Orthofix International N.V. Orthobiologics Product Portfolio
6.5.5 Orthofix International N.V. Recent Developments/Updates
6.6 Anika Therapeutics, Inc.
6.6.1 Anika Therapeutics, Inc. Corporation Information
6.6.2 Anika Therapeutics, Inc. Description and Business Overview
6.6.3 Anika Therapeutics, Inc. Orthobiologics Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Anika Therapeutics, Inc. Orthobiologics Product Portfolio
6.6.5 Anika Therapeutics, Inc. Recent Developments/Updates
6.7 DePuy Synthes (Johnson & Johnson)
6.6.1 DePuy Synthes (Johnson & Johnson) Corporation Information
6.6.2 DePuy Synthes (Johnson & Johnson) Description and Business Overview
6.6.3 DePuy Synthes (Johnson & Johnson) Orthobiologics Sales, Revenue and Gross Margin (2018-2023)
6.4.4 DePuy Synthes (Johnson & Johnson) Orthobiologics Product Portfolio
6.7.5 DePuy Synthes (Johnson & Johnson) Recent Developments/Updates
6.8 Bioventus
6.8.1 Bioventus Corporation Information
6.8.2 Bioventus Description and Business Overview
6.8.3 Bioventus Orthobiologics Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Bioventus Orthobiologics Product Portfolio
6.8.5 Bioventus Recent Developments/Updates
6.9 Arthrex, Inc.
6.9.1 Arthrex, Inc. Corporation Information
6.9.2 Arthrex, Inc. Description and Business Overview
6.9.3 Arthrex, Inc. Orthobiologics Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Arthrex, Inc. Orthobiologics Product Portfolio
6.9.5 Arthrex, Inc. Recent Developments/Updates
6.10 SeaSpine Holdings Corporation
6.10.1 SeaSpine Holdings Corporation Corporation Information
6.10.2 SeaSpine Holdings Corporation Description and Business Overview
6.10.3 SeaSpine Holdings Corporation Orthobiologics Sales, Revenue and Gross Margin (2018-2023)
6.10.4 SeaSpine Holdings Corporation Orthobiologics Product Portfolio
6.10.5 SeaSpine Holdings Corporation Recent Developments/Updates
6.11 Sanofi-Aventis (Sanofi SA)
6.11.1 Sanofi-Aventis (Sanofi SA) Corporation Information
6.11.2 Sanofi-Aventis (Sanofi SA) Orthobiologics Description and Business Overview
6.11.3 Sanofi-Aventis (Sanofi SA) Orthobiologics Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Sanofi-Aventis (Sanofi SA) Orthobiologics Product Portfolio
6.11.5 Sanofi-Aventis (Sanofi SA) Recent Developments/Updates
6.12 Djo Global, Inc.
6.12.1 Djo Global, Inc. Corporation Information
6.12.2 Djo Global, Inc. Orthobiologics Description and Business Overview
6.12.3 Djo Global, Inc. Orthobiologics Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Djo Global, Inc. Orthobiologics Product Portfolio
6.12.5 Djo Global, Inc. Recent Developments/Updates
6.13 Seikagaku Corporation
6.13.1 Seikagaku Corporation Corporation Information
6.13.2 Seikagaku Corporation Orthobiologics Description and Business Overview
6.13.3 Seikagaku Corporation Orthobiologics Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Seikagaku Corporation Orthobiologics Product Portfolio
6.13.5 Seikagaku Corporation Recent Developments/Updates
6.14 RTI Surgical, Inc.
6.14.1 RTI Surgical, Inc. Corporation Information
6.14.2 RTI Surgical, Inc. Orthobiologics Description and Business Overview
6.14.3 RTI Surgical, Inc. Orthobiologics Sales, Revenue and Gross Margin (2018-2023)
6.14.4 RTI Surgical, Inc. Orthobiologics Product Portfolio
6.14.5 RTI Surgical, Inc. Recent Developments/Updates
6.15 Heraeus Holding GmbH
6.15.1 Heraeus Holding GmbH Corporation Information
6.15.2 Heraeus Holding GmbH Orthobiologics Description and Business Overview
6.15.3 Heraeus Holding GmbH Orthobiologics Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Heraeus Holding GmbH Orthobiologics Product Portfolio
6.15.5 Heraeus Holding GmbH Recent Developments/Updates
6.16 Fidia Pharma USA Inc.
6.16.1 Fidia Pharma USA Inc. Corporation Information
6.16.2 Fidia Pharma USA Inc. Orthobiologics Description and Business Overview
6.16.3 Fidia Pharma USA Inc. Orthobiologics Sales, Revenue and Gross Margin (2018-2023)
6.16.4 Fidia Pharma USA Inc. Orthobiologics Product Portfolio
6.16.5 Fidia Pharma USA Inc. Recent Developments/Updates
6.17 TRB Chemedica International SA
6.17.1 TRB Chemedica International SA Corporation Information
6.17.2 TRB Chemedica International SA Orthobiologics Description and Business Overview
6.17.3 TRB Chemedica International SA Orthobiologics Sales, Revenue and Gross Margin (2018-2023)
6.17.4 TRB Chemedica International SA Orthobiologics Product Portfolio
6.17.5 TRB Chemedica International SA Recent Developments/Updates
6.18 Allosource
6.18.1 Allosource Corporation Information
6.18.2 Allosource Orthobiologics Description and Business Overview
6.18.3 Allosource Orthobiologics Sales, Revenue and Gross Margin (2018-2023)
6.18.4 Allosource Orthobiologics Product Portfolio
6.18.5 Allosource Recent Developments/Updates
6.19 Musculoskeletal Transplant Foundation, Inc.
6.19.1 Musculoskeletal Transplant Foundation, Inc. Corporation Information
6.19.2 Musculoskeletal Transplant Foundation, Inc. Orthobiologics Description and Business Overview
6.19.3 Musculoskeletal Transplant Foundation, Inc. Orthobiologics Sales, Revenue and Gross Margin (2018-2023)
6.19.4 Musculoskeletal Transplant Foundation, Inc. Orthobiologics Product Portfolio
6.19.5 Musculoskeletal Transplant Foundation, Inc. Recent Developments/Updates
6.20 Ito
6.20.1 Ito Corporation Information
6.20.2 Ito Orthobiologics Description and Business Overview
6.20.3 Ito Orthobiologics Sales, Revenue and Gross Margin (2018-2023)
6.20.4 Ito Orthobiologics Product Portfolio
6.20.5 Ito Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Orthobiologics Industry Chain Analysis
7.2 Orthobiologics Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Orthobiologics Production Mode & Process
7.4 Orthobiologics Sales and Marketing
7.4.1 Orthobiologics Sales Channels
7.4.2 Orthobiologics Distributors
7.5 Orthobiologics Customers
8 Orthobiologics Market Dynamics
8.1 Orthobiologics Industry Trends
8.2 Orthobiologics Market Drivers
8.3 Orthobiologics Market Challenges
8.4 Orthobiologics Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
    Table 1. Global Orthobiologics Market Value Comparison by Type (2023-2029) & (US$ Million)
    Table 2. Global Orthobiologics Market Value Comparison by Application (2023-2029) & (US$ Million)
    Table 3. Global Orthobiologics Market Competitive Situation by Manufacturers in 2022
    Table 4. Global Orthobiologics Sales (K Units) of Key Manufacturers (2018-2023)
    Table 5. Global Orthobiologics Sales Market Share by Manufacturers (2018-2023)
    Table 6. Global Orthobiologics Revenue (US$ Million) by Manufacturers (2018-2023)
    Table 7. Global Orthobiologics Revenue Share by Manufacturers (2018-2023)
    Table 8. Global Market Orthobiologics Average Price (USD/Unit) of Key Manufacturers (2018-2023)
    Table 9. Global Key Players of Orthobiologics, Industry Ranking, 2021 VS 2022 VS 2023
    Table 10. Global Key Manufacturers of Orthobiologics, Manufacturing Sites & Headquarters
    Table 11. Global Key Manufacturers of Orthobiologics, Product Type & Application
    Table 12. Global Key Manufacturers of Orthobiologics, Date of Enter into This Industry
    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Orthobiologics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Orthobiologics as of 2022)
    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 16. Global Orthobiologics Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 17. Global Orthobiologics Sales by Region (2018-2023) & (K Units)
    Table 18. Global Orthobiologics Sales Market Share by Region (2018-2023)
    Table 19. Global Orthobiologics Sales by Region (2024-2029) & (K Units)
    Table 20. Global Orthobiologics Sales Market Share by Region (2024-2029)
    Table 21. Global Orthobiologics Revenue by Region (2018-2023) & (US$ Million)
    Table 22. Global Orthobiologics Revenue Market Share by Region (2018-2023)
    Table 23. Global Orthobiologics Revenue by Region (2024-2029) & (US$ Million)
    Table 24. Global Orthobiologics Revenue Market Share by Region (2024-2029)
    Table 25. North America Orthobiologics Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 26. North America Orthobiologics Sales by Country (2018-2023) & (K Units)
    Table 27. North America Orthobiologics Sales by Country (2024-2029) & (K Units)
    Table 28. North America Orthobiologics Revenue by Country (2018-2023) & (US$ Million)
    Table 29. North America Orthobiologics Revenue by Country (2024-2029) & (US$ Million)
    Table 30. Europe Orthobiologics Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 31. Europe Orthobiologics Sales by Country (2018-2023) & (K Units)
    Table 32. Europe Orthobiologics Sales by Country (2024-2029) & (K Units)
    Table 33. Europe Orthobiologics Revenue by Country (2018-2023) & (US$ Million)
    Table 34. Europe Orthobiologics Revenue by Country (2024-2029) & (US$ Million)
    Table 35. Asia Pacific Orthobiologics Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
    Table 36. Asia Pacific Orthobiologics Sales by Region (2018-2023) & (K Units)
    Table 37. Asia Pacific Orthobiologics Sales by Region (2024-2029) & (K Units)
    Table 38. Asia Pacific Orthobiologics Revenue by Region (2018-2023) & (US$ Million)
    Table 39. Asia Pacific Orthobiologics Revenue by Region (2024-2029) & (US$ Million)
    Table 40. Latin America Orthobiologics Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 41. Latin America Orthobiologics Sales by Country (2018-2023) & (K Units)
    Table 42. Latin America Orthobiologics Sales by Country (2024-2029) & (K Units)
    Table 43. Latin America Orthobiologics Revenue by Country (2018-2023) & (US$ Million)
    Table 44. Latin America Orthobiologics Revenue by Country (2024-2029) & (US$ Million)
    Table 45. Middle East & Africa Orthobiologics Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 46. Middle East & Africa Orthobiologics Sales by Country (2018-2023) & (K Units)
    Table 47. Middle East & Africa Orthobiologics Sales by Country (2024-2029) & (K Units)
    Table 48. Middle East & Africa Orthobiologics Revenue by Country (2018-2023) & (US$ Million)
    Table 49. Middle East & Africa Orthobiologics Revenue by Country (2024-2029) & (US$ Million)
    Table 50. Global Orthobiologics Sales (K Units) by Type (2018-2023)
    Table 51. Global Orthobiologics Sales (K Units) by Type (2024-2029)
    Table 52. Global Orthobiologics Sales Market Share by Type (2018-2023)
    Table 53. Global Orthobiologics Sales Market Share by Type (2024-2029)
    Table 54. Global Orthobiologics Revenue (US$ Million) by Type (2018-2023)
    Table 55. Global Orthobiologics Revenue (US$ Million) by Type (2024-2029)
    Table 56. Global Orthobiologics Revenue Market Share by Type (2018-2023)
    Table 57. Global Orthobiologics Revenue Market Share by Type (2024-2029)
    Table 58. Global Orthobiologics Price (USD/Unit) by Type (2018-2023)
    Table 59. Global Orthobiologics Price (USD/Unit) by Type (2024-2029)
    Table 60. Global Orthobiologics Sales (K Units) by Application (2018-2023)
    Table 61. Global Orthobiologics Sales (K Units) by Application (2024-2029)
    Table 62. Global Orthobiologics Sales Market Share by Application (2018-2023)
    Table 63. Global Orthobiologics Sales Market Share by Application (2024-2029)
    Table 64. Global Orthobiologics Revenue (US$ Million) by Application (2018-2023)
    Table 65. Global Orthobiologics Revenue (US$ Million) by Application (2024-2029)
    Table 66. Global Orthobiologics Revenue Market Share by Application (2018-2023)
    Table 67. Global Orthobiologics Revenue Market Share by Application (2024-2029)
    Table 68. Global Orthobiologics Price (USD/Unit) by Application (2018-2023)
    Table 69. Global Orthobiologics Price (USD/Unit) by Application (2024-2029)
    Table 70. Medtronic Corporation Information
    Table 71. Medtronic Description and Business Overview
    Table 72. Medtronic Orthobiologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 73. Medtronic Orthobiologics Product
    Table 74. Medtronic Recent Developments/Updates
    Table 75. NuVasive, Inc. Corporation Information
    Table 76. NuVasive, Inc. Description and Business Overview
    Table 77. NuVasive, Inc. Orthobiologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 78. NuVasive, Inc. Orthobiologics Product
    Table 79. NuVasive, Inc. Recent Developments/Updates
    Table 80. Stryker Corporation Corporation Information
    Table 81. Stryker Corporation Description and Business Overview
    Table 82. Stryker Corporation Orthobiologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 83. Stryker Corporation Orthobiologics Product
    Table 84. Stryker Corporation Recent Developments/Updates
    Table 85. Zimmer Biomet Holdings Corporation Information
    Table 86. Zimmer Biomet Holdings Description and Business Overview
    Table 87. Zimmer Biomet Holdings Orthobiologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 88. Zimmer Biomet Holdings Orthobiologics Product
    Table 89. Zimmer Biomet Holdings Recent Developments/Updates
    Table 90. Orthofix International N.V. Corporation Information
    Table 91. Orthofix International N.V. Description and Business Overview
    Table 92. Orthofix International N.V. Orthobiologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 93. Orthofix International N.V. Orthobiologics Product
    Table 94. Orthofix International N.V. Recent Developments/Updates
    Table 95. Anika Therapeutics, Inc. Corporation Information
    Table 96. Anika Therapeutics, Inc. Description and Business Overview
    Table 97. Anika Therapeutics, Inc. Orthobiologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 98. Anika Therapeutics, Inc. Orthobiologics Product
    Table 99. Anika Therapeutics, Inc. Recent Developments/Updates
    Table 100. DePuy Synthes (Johnson & Johnson) Corporation Information
    Table 101. DePuy Synthes (Johnson & Johnson) Description and Business Overview
    Table 102. DePuy Synthes (Johnson & Johnson) Orthobiologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 103. DePuy Synthes (Johnson & Johnson) Orthobiologics Product
    Table 104. DePuy Synthes (Johnson & Johnson) Recent Developments/Updates
    Table 105. Bioventus Corporation Information
    Table 106. Bioventus Description and Business Overview
    Table 107. Bioventus Orthobiologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 108. Bioventus Orthobiologics Product
    Table 109. Bioventus Recent Developments/Updates
    Table 110. Arthrex, Inc. Corporation Information
    Table 111. Arthrex, Inc. Description and Business Overview
    Table 112. Arthrex, Inc. Orthobiologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 113. Arthrex, Inc. Orthobiologics Product
    Table 114. Arthrex, Inc. Recent Developments/Updates
    Table 115. SeaSpine Holdings Corporation Corporation Information
    Table 116. SeaSpine Holdings Corporation Description and Business Overview
    Table 117. SeaSpine Holdings Corporation Orthobiologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 118. SeaSpine Holdings Corporation Orthobiologics Product
    Table 119. SeaSpine Holdings Corporation Recent Developments/Updates
    Table 120. Sanofi-Aventis (Sanofi SA) Corporation Information
    Table 121. Sanofi-Aventis (Sanofi SA) Description and Business Overview
    Table 122. Sanofi-Aventis (Sanofi SA) Orthobiologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 123. Sanofi-Aventis (Sanofi SA) Orthobiologics Product
    Table 124. Sanofi-Aventis (Sanofi SA) Recent Developments/Updates
    Table 125. Djo Global, Inc. Corporation Information
    Table 126. Djo Global, Inc. Description and Business Overview
    Table 127. Djo Global, Inc. Orthobiologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 128. Djo Global, Inc. Orthobiologics Product
    Table 129. Djo Global, Inc. Recent Developments/Updates
    Table 130. Seikagaku Corporation Corporation Information
    Table 131. Seikagaku Corporation Description and Business Overview
    Table 132. Seikagaku Corporation Orthobiologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 133. Seikagaku Corporation Orthobiologics Product
    Table 134. Seikagaku Corporation Recent Developments/Updates
    Table 135. RTI Surgical, Inc. Corporation Information
    Table 136. RTI Surgical, Inc. Description and Business Overview
    Table 137. RTI Surgical, Inc. Orthobiologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 138. RTI Surgical, Inc. Orthobiologics Product
    Table 139. RTI Surgical, Inc. Recent Developments/Updates
    Table 140. Heraeus Holding GmbH Corporation Information
    Table 141. Heraeus Holding GmbH Description and Business Overview
    Table 142. Heraeus Holding GmbH Orthobiologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 143. Heraeus Holding GmbH Orthobiologics Product
    Table 144. Heraeus Holding GmbH Recent Developments/Updates
    Table 145. Fidia Pharma USA Inc. Corporation Information
    Table 146. Fidia Pharma USA Inc. Description and Business Overview
    Table 147. Fidia Pharma USA Inc. Orthobiologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 148. Fidia Pharma USA Inc. Orthobiologics Product
    Table 149. Fidia Pharma USA Inc. Recent Developments/Updates
    Table 150. TRB Chemedica International SA Corporation Information
    Table 151. TRB Chemedica International SA Description and Business Overview
    Table 152. TRB Chemedica International SA Orthobiologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 153. TRB Chemedica International SA Orthobiologics Product
    Table 154. TRB Chemedica International SA Recent Developments/Updates
    Table 155. Allosource Corporation Information
    Table 156. Allosource Description and Business Overview
    Table 157. Allosource Orthobiologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 158. Allosource Orthobiologics Product
    Table 159. Allosource Recent Developments/Updates
    Table 160. Musculoskeletal Transplant Foundation, Inc. Corporation Information
    Table 161. Musculoskeletal Transplant Foundation, Inc. Description and Business Overview
    Table 162. Musculoskeletal Transplant Foundation, Inc. Orthobiologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 163. Musculoskeletal Transplant Foundation, Inc. Orthobiologics Product
    Table 164. Musculoskeletal Transplant Foundation, Inc. Recent Developments/Updates
    Table 165. Ito Corporation Information
    Table 166. Ito Description and Business Overview
    Table 167. Ito Orthobiologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 168. Ito Orthobiologics Product
    Table 169. Ito Recent Developments/Updates
    Table 170. Key Raw Materials Lists
    Table 171. Raw Materials Key Suppliers Lists
    Table 172. Orthobiologics Distributors List
    Table 173. Orthobiologics Customers List
    Table 174. Orthobiologics Market Trends
    Table 175. Orthobiologics Market Drivers
    Table 176. Orthobiologics Market Challenges
    Table 177. Orthobiologics Market Restraints
    Table 178. Research Programs/Design for This Report
    Table 179. Key Data Information from Secondary Sources
    Table 180. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Orthobiologics
    Figure 2. Global Orthobiologics Market Value Comparison by Type (2023-2029) & (US$ Million)
    Figure 3. Global Orthobiologics Market Share by Type in 2022 & 2029
    Figure 4. Bone Growth Stimulators (BGS) Product Picture
    Figure 5. Viscosupplements Product Picture
    Figure 6. Bone Graft Substitute Product Picture
    Figure 7. Global Orthobiologics Market Value Comparison by Application (2023-2029) & (US$ Million)
    Figure 8. Global Orthobiologics Market Share by Application in 2022 & 2029
    Figure 9. Hospitals
    Figure 10. Ambulatory Surgical Centres
    Figure 11. Orthopaedics Clinics
    Figure 12. Global Orthobiologics Revenue, (US$ Million), 2018 VS 2022 VS 2029
    Figure 13. Global Orthobiologics Market Size (2018-2029) & (US$ Million)
    Figure 14. Global Orthobiologics Sales (2018-2029) & (K Units)
    Figure 15. Global Orthobiologics Average Price (USD/Unit) & (2018-2029)
    Figure 16. Orthobiologics Report Years Considered
    Figure 17. Orthobiologics Sales Share by Manufacturers in 2022
    Figure 18. Global Orthobiologics Revenue Share by Manufacturers in 2022
    Figure 19. The Global 5 and 10 Largest Orthobiologics Players: Market Share by Revenue in 2022
    Figure 20. Orthobiologics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
    Figure 21. Global Orthobiologics Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
    Figure 22. North America Orthobiologics Sales Market Share by Country (2018-2029)
    Figure 23. North America Orthobiologics Revenue Market Share by Country (2018-2029)
    Figure 24. U.S. Orthobiologics Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 25. Canada Orthobiologics Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 26. Europe Orthobiologics Sales Market Share by Country (2018-2029)
    Figure 27. Europe Orthobiologics Revenue Market Share by Country (2018-2029)
    Figure 28. Germany Orthobiologics Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 29. France Orthobiologics Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 30. U.K. Orthobiologics Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 31. Italy Orthobiologics Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 32. Russia Orthobiologics Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 33. Asia Pacific Orthobiologics Sales Market Share by Region (2018-2029)
    Figure 34. Asia Pacific Orthobiologics Revenue Market Share by Region (2018-2029)
    Figure 35. China Orthobiologics Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 36. Japan Orthobiologics Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 37. South Korea Orthobiologics Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 38. India Orthobiologics Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 39. Australia Orthobiologics Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 40. China Taiwan Orthobiologics Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 41. Indonesia Orthobiologics Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 42. Thailand Orthobiologics Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 43. Malaysia Orthobiologics Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 44. Latin America Orthobiologics Sales Market Share by Country (2018-2029)
    Figure 45. Latin America Orthobiologics Revenue Market Share by Country (2018-2029)
    Figure 46. Mexico Orthobiologics Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 47. Brazil Orthobiologics Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 48. Argentina Orthobiologics Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 49. Middle East & Africa Orthobiologics Sales Market Share by Country (2018-2029)
    Figure 50. Middle East & Africa Orthobiologics Revenue Market Share by Country (2018-2029)
    Figure 51. Turkey Orthobiologics Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 52. Saudi Arabia Orthobiologics Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 53. UAE Orthobiologics Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 54. Global Sales Market Share of Orthobiologics by Type (2018-2029)
    Figure 55. Global Revenue Market Share of Orthobiologics by Type (2018-2029)
    Figure 56. Global Orthobiologics Price (USD/Unit) by Type (2018-2029)
    Figure 57. Global Sales Market Share of Orthobiologics by Application (2018-2029)
    Figure 58. Global Revenue Market Share of Orthobiologics by Application (2018-2029)
    Figure 59. Global Orthobiologics Price (USD/Unit) by Application (2018-2029)
    Figure 60. Orthobiologics Value Chain
    Figure 61. Orthobiologics Production Process
    Figure 62. Channels of Distribution (Direct Vs Distribution)
    Figure 63. Distributors Profiles
    Figure 64. Bottom-up and Top-down Approaches for This Report
    Figure 65. Data Triangulation
    Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Ephedrine Market Research Report 2023

120 Pages
Type: Report
Code: QYRE-Auto-18G9846
Thu Apr 27 00:00:00 UTC 2023

Add to Cart

Global Pemirolast Market Research Report 2023

120 Pages
Type: Report
Code: QYRE-Auto-31D3357
Thu Apr 27 00:00:00 UTC 2023

Add to Cart

Global Xanthine Market Research Report 2023

120 Pages
Type: Report
Code: QYRE-Auto-19B3563
Thu Apr 27 00:00:00 UTC 2023

Add to Cart

Global Animal Free Trypsin Market Research Report 2023

120 Pages
Type: Report
Code: QYRE-Auto-38D13877
Wed Apr 26 00:00:00 UTC 2023

Add to Cart